<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>iReg | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2021-01-15T16:56:43+08:00</updated>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>FDA发的指南超过日欧中的总和</title>
    <updated>2021-01-15T14:19:34+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-15:/s/GZgu1ir9OZYmG7JrmqrI3g</id>
    <link href="https://mp.weixin.qq.com/s/GZgu1ir9OZYmG7JrmqrI3g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>国内指南学习：化药创新药I期申请药学共性问题相关技术要求</title>
    <updated>2020-12-13T13:09:41+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-13:/s/r_IzsxFiZF-kL9OSOC3mWw</id>
    <link href="https://mp.weixin.qq.com/s/r_IzsxFiZF-kL9OSOC3mWw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>ICH指南学习：Q3A 案例分析：溶出度</title>
    <updated>2020-12-08T22:54:52+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-08:/s/Mf5eoHQkJ0yO30pGQP1JfA</id>
    <link href="https://mp.weixin.qq.com/s/Mf5eoHQkJ0yO30pGQP1JfA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>ICH指南学习：Q3A 化药的质量标准 (1)</title>
    <updated>2020-12-07T18:36:33+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-07:/s/wRJi56NDNdo1HicPm5eA_w</id>
    <link href="https://mp.weixin.qq.com/s/wRJi56NDNdo1HicPm5eA_w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>ICH指南学习：Q3D元素杂质指导原则</title>
    <updated>2020-12-06T14:17:34+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-06:/s/wTiUH5XDYr5Y87ET1A5hTA</id>
    <link href="https://mp.weixin.qq.com/s/wTiUH5XDYr5Y87ET1A5hTA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>ICH 指南学习： Q1系列稳定性指南</title>
    <updated>2020-12-03T18:38:24+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-03:/s/gzRbhxTMP5kWHqoC1wZNmQ</id>
    <link href="https://mp.weixin.qq.com/s/gzRbhxTMP5kWHqoC1wZNmQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>ICH指南学习：E2B(R3）和E2D</title>
    <updated>2020-12-01T17:24:48+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-01:/s/UgdUPItEX5sRf5d6NnjfUQ</id>
    <link href="https://mp.weixin.qq.com/s/UgdUPItEX5sRf5d6NnjfUQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>ICH 指南学习：E2A 临床安全数据的管理：快速报告的定义和标准</title>
    <updated>2020-11-30T10:24:05+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-30:/s/xxlVkPsXDTbk70IkTx0Mkg</id>
    <link href="https://mp.weixin.qq.com/s/xxlVkPsXDTbk70IkTx0Mkg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>ICH指南学习：E2E药物警戒计划</title>
    <updated>2020-11-30T10:13:18+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-30:/s/uK675o5itWi38jMwABST6Q</id>
    <link href="https://mp.weixin.qq.com/s/uK675o5itWi38jMwABST6Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>ICH 指南学习： E3临床研究报告的结构和内容</title>
    <updated>2020-11-29T15:47:02+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-29:/s/8DLvL0iT1o9-m059RTNGMg</id>
    <link href="https://mp.weixin.qq.com/s/8DLvL0iT1o9-m059RTNGMg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>